A prognostic model for advanced stage nonsmall cell lung cancer. Pooled analysis of North Central Cancer Treatment Group trials.

Mandrekar, Sumithra J; Schild, Steven E; Hillman, Shauna L; Allen, Katie L; Marks, Randolph S; Mailliard, James A; Krook, James E; Maksymiuk, Andrew W; Chansky, Kari; Kelly, Karen; Adjei, Alex A; Jett, James R

Mandrekar, Sumithra J; Schild, Steven E; Hillman, Shauna L; Allen, Katie L; Marks, Randolph S; Mailliard, James A; Krook, James E; Maksymiuk, Andrew W; Chansky, Kari; Kelly, Karen; Adjei, Alex A; Jett, James R.

Affiliation

Mandrekar SJ; Mayo Clinic College of Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA. mandrekar.sumithra@mayo.edu

Cancer ; 107(4): 781-92, 2006 Aug 15.

Article in En | MEDLINE | ID: mdl-16847887

Subject(s)

Carcinoma, Non-Small-Cell Lung/diagnosis; Lung Neoplasms/diagnosis; Models, Biological; Aged; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Blood Platelets/metabolism; Body Mass Index; Carcinoma, Non-Small-Cell Lung/drug therapy; Carcinoma, Non-Small-Cell Lung/metabolism; Creatinine/metabolism; Female; Hemoglobins/metabolism; Humans; Lung Neoplasms/drug therapy; Lung Neoplasms/metabolism; Male; Neoplasm Staging; Prognosis; Survival Rate; Time Factors; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms / Models, Biological Type of study: Prognostic_studies Limits: Aged / Female / Humans / Male Language: En Journal: Cancer Year: 2006 Type: Article Affiliation country: United States

Search on Google

Add to My VHL

XML

PubMed Links